[Treatment of cerebral circulatory insufficiency in latent cardiac insufficiency].
D000368:Aged; D001549:Benzamides / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology; D004077:Digoxin / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D013806:Theophylline / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D001549:Benzamides; D001565:Benzoates; D000697:Central Nervous System Stimulants; D014665:Vasodilator Agents; D004077:Digoxin; D013806:Theophylline
Zur Behandlung der zerebralen Mangeldrchblutung bei latenter Herzinsuffizienz.